These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 1316230
1. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Powis G, Seewald MJ, Gratas C, Melder D, Riebow J, Modest EJ. Cancer Res; 1992 May 15; 52(10):2835-40. PubMed ID: 1316230 [Abstract] [Full Text] [Related]
5. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L). Mollinedo F, Fernández-Luna JL, Gajate C, Martín-Martín B, Benito A, Martínez-Dalmau R, Modolell M. Cancer Res; 1997 Apr 01; 57(7):1320-8. PubMed ID: 9102220 [Abstract] [Full Text] [Related]
6. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha. Daniel LW, Civoli F, Rogers MA, Smitherman PK, Raju PA, Roederer M. Cancer Res; 1995 Nov 01; 55(21):4844-9. PubMed ID: 7585518 [Abstract] [Full Text] [Related]
7. A high level of cell surface phosphatidylinositol-specific phospholipase C activity is characteristic of growth-arrested 3T3 fibroblasts but not of transformed variants. Volwerk JJ, Birrell GB, Hedberg KK, Griffith OH. J Cell Physiol; 1992 Jun 01; 151(3):613-22. PubMed ID: 1338336 [Abstract] [Full Text] [Related]
8. Inhibition of phospholipase D by agents that inhibit cell growth. Gratas C, Powis G. Anticancer Res; 1993 Jun 01; 13(4):1239-44. PubMed ID: 8352550 [Abstract] [Full Text] [Related]
9. The differential susceptibility of A427 and A549 cell lines to the growth-inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids. Lu X, Arthur G. Cancer Res; 1992 May 15; 52(10):2813-7. PubMed ID: 1581895 [Abstract] [Full Text] [Related]
11. The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D. Wilcox RW, Wykle RL, Schmitt JD, Daniel LW. Lipids; 1987 Nov 15; 22(11):800-7. PubMed ID: 3444369 [Abstract] [Full Text] [Related]
13. The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1. Samadder P, Richards C, Bittman R, Bhullar RP, Arthur G. Anticancer Res; 2003 Nov 15; 23(3B):2291-5. PubMed ID: 12894505 [Abstract] [Full Text] [Related]
17. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities. Unger C, Eibl H, Kim DJ, Fleer EA, Kötting J, Bartsch HH, Nagel GA, Pfizenmaier K. J Natl Cancer Inst; 1987 Feb 15; 78(2):219-22. PubMed ID: 3468284 [Abstract] [Full Text] [Related]
18. Inhibition by an alkyl-lysophospholipid of the uptake of epidermal growth factor in human breast cancer cell lines in relation to epidermal growth factor internalization. Kosano H, Takatani O. Cancer Res; 1989 Jun 01; 49(11):2868-70. PubMed ID: 2785846 [Abstract] [Full Text] [Related]
20. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine). Marino-Albernas JR, Bittman R, Peters A, Mayhew E. J Med Chem; 1996 Aug 16; 39(17):3241-7. PubMed ID: 8765506 [Abstract] [Full Text] [Related] Page: [Next] [New Search]